Oslo, May 13, 2022 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, June 3 2022 at 10:00 (CET). The annual general meeting will be held at Haakon VIIs gate 2, 0161 Oslo for those attending in person and via Lumi for those attending digitally. Voting…
Read moreOslo, 29 April 2022 – Observe Medical ASA ("the Company" or "Observe Medical") today announces that the Company has published its Annual Report for 2021, which was approved by the board of directors on 28 April 2022. "It has been a transformational start to 2022, so I would like to take this opportunity to focus…
Read moreOslo, 29 March 2022 – Observe Medical ASA (“the Company” or “Observe Medical”) today releases a combined business update and interim financial results for the fourth quarter and full year 2021. Observe Medical can also report that 202 out of 260 Biim ultrasound probes have been successfully shipped. Another 58 Biim probes will be delivered…
Read moreThe Board of Directors has today appointed Rune Nystad as Chief Executive Officer (CEO) of Observe Medical ASA (the “Company” or “Observe Medical”), a Nordic medtech company with global reach. He succeeds Björn Larsson, who has headed the Company since 2019. Rune Nystad was previously the CEO of Biim Ultrasound, a company recently acquired by…
Read moreOslo, 10 March 2022: Reference is made to the stock exchange announcement by Observe Medical ASA (the "Company") on 8 March 2022 regarding the Company's completion of the acquisition of Biim Ultrasound AS and the issuance of 8,171,913 new shares in the Company as partial consideration to the sellers of Biim Ultrasound AS (the "Consideration…
Read moreOslo, 8 March 2022: Observe Medical ASA (OSE: OBSRV) (the "Company" or Observe Medical") is excited to announce the completion of the acquisition of Biim Ultrasound AS ("Biim Ultrasound"), an international medical ultrasound technology company, adding another innovative product that improves patient welfare and outcome and that promotes positive health economics to its portfolio. With…
Read more7 March 2022: Reference is made to the stock exchange announcement published by Observe Medical ASA (the "Company ") on 24 February 2022, regarding the final result of the rights issue of 25,714,286 new shares in the Company (the "Offer Shares") at a subscription price of NOK 7.00 per Offer Share (the "Rights Issue"). The…
Read moreReference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") on 21 February 2022, regarding the exercise of subscription rights in the rights issue by certain primary insiders and a close associate of a primary insider, and today, on 24 February 2022 regarding the final results of the rights issue…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreReference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 9 February 2022, regarding the commencement of the subscription period in the rights issue of 25,714,286 new shares in the Company (the "Offer Shares") at a subscription price of NOK 7.00 per offer share (the "Rights Issue"). Thomas Grunfeld,…
Read moreMandatory disclosure pursuant to section 4-2 of the Norwegian Securities Trading Act by Navamedic ASA. Reference is made to the previous stock exchange announcements from Observe Medical ASA (the "Company") announcing a fully underwritten rights issue of 25,714,286 new shares in the Company, raising gross proceeds of approximately NOK 180 million (the "Rights Issue"). In…
Read moreReference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") on 9 February 2022, regarding the commencement of the subscription period in the rights issue (the "Rights Issue") and the receipt of subscription rights in the Rights Issue by certain primary insiders and certain close associates of primary insiders of…
Read moreReference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") on 9 February 2022, regarding the commencement of the subscription period in the rights issue of 25,714,286 new shares in the Company (the "Offer Shares") at a subscription price of NOK 7.00 per offer share (the "Rights Issue"). Thomas Grunfeld,…
Read moreReference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") on 9 February 2022, regarding the commencement of the subscription period in the rights issue (the "Rights Issue") and the receipt of subscription rights in the Rights Issue by certain primary insiders and certain close associates of primary insiders of…
Read moreOslo, February 21, 2022 – Observe Medical ASA (OSE: OBSRV) today announces a new order for Sippi systems, from our distributor in Poland, Skamex. Observe Medical ASA (the "Company") has today, on 21 February 2022, received an order for 30 Sippi® Base units and 300 Sippi® Disposable units from Skamex. The total order value…
Read moreMandatory disclosure pursuant to section 4-2 of the Norwegian Securities Trading Act by TopRidge Pharma (Ireland) Limited ("TopRidge Pharma"). Reference is made to the previous stock exchange announcements from Observe Medical ASA (the "Company") announcing a fully underwritten rights issue of 25,714,286 new shares in the Company, raising gross proceeds of approximately NOK 180 million…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreReference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 9 February 2022, regarding the commencement of the subscription period in the rights issue (the "Rights Issue"). Please see the attached notifications of trade for information regarding the primary insiders' and their close associates' receipt of subscription…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreOslo, February 7, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter (in Norwegian) in relation to the fully underwritten rights issue in…
Read moreIssuer name: Observe Medical ASA Ex.date: 7 February 2022 Type of corporate action: Rights issue This information is published in accordance with the requirements of the Continuing Obligations.
Read moreReference is made to the stock exchange announcements published by Observe Medical ASA (the "Company") on 14 January 2022 regarding a proposed fully underwritten rights issue in the Company (the "Rights Issue"). The extraordinary general meeting of the Company has today, on 4 February 2022, approved the Rights Issue and the authorisation to the board…
Read moreReference is made to the key information relating to the preferential rights issue published by Observe Medical ASA (the "Company") on 14 January 2022. Please see below for updated key information relating to the preferential rights issue to be carried out by the Company: Date on which the terms and conditions of the preferential rights…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read moreOslo, 2 February 2022: In connection with the extraordinary general meeting of Observe Medical ASA (the "Company") to be held on 4 February 2022 (the "EGM"), Terje Bakken, chairman of the board of directors of the Company, has as at the close of trading on the Oslo Stock Exchange on 2 February 2022, received proxies…
Read more· Observe Medical will develop and commercialize proprietary, innovative medtech products to the global market · International distributor and partner network with a Nordic direct sales organization · The agreement is set to accelerate the global commercial roll-out of the combined portfolio, including Sippi® US market launch and the entry of Biim in Europe Oslo,…
Read moreReference is made to the stock exchange announcement published by Observe Medical ASA (the "Company") earlier today, on 14 January 2022, regarding the resolution by the Company's board of directors to propose that the Company carries out a share capital increase, by way of a fully underwritten rights issue, to raise gross proceeds of NOK…
Read moreNOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE'S REPUBLIC OF CHINA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT NOTICE AT THE END…
Read more16 November 2021: The board of directors of Observe Medical ASA (the "Company") has resolved to grant 120,000 share options in the Company to the group CFO, Per Arne Nygård. Per Arne Nygård was engaged as interim CFO of the group as an consultant on 10 December 2019, and was permanently employed as CFO of…
Read moreOslo, November, 3rd, 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the third quarter of 2021. The Company reports strong revenue growth for the Nordic portfolio, continued progress in the commercialization and go-to-market execution for Sippi® including an update on preparations for US market entry. CEO of Observe Medical,…
Read moreObserve Medical ASA invites you to a presentation of the third quarter 2021. The presentation will take place at Felix Konferansesenter in Oslo on Wednesday, November 3rd. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20211103_5/ Representatives from the Company will…
Read moreFINANCIAL YEAR 2021 03.11.2021 – Quarterly Presentation – Q3 17.02.2022 – Quarterly Presentation – Q4 29.04.2022 – Annual Report 02.06.2022 – Annual General Meeting FINANCIAL YEAR 2022 12.05.2022 – Quarterly Presentation – Q1 25.08.2022 – Second quarter and Half-year Report 03.11.2022 – Quarterly Report – Q3 This information is published pursuant to the requirements set out…
Read moreOslo, August 20[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its financial results and presentation of the second quarter and first half-year of 2021, reporting continuous progress in the go-to-market execution for Sippi®, a unique and proprietary solution for digital, automated urine monitoring. “We have a sharp focus on continuous roll-out of Sippi®,…
Read moreObserve Medical ASA invites you to a presentation of the second quarter and first half year 2021. The presentation will take place at Felix Konferansesenter in Oslo on Friday, August 20th. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and at the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210820_3/ …
Read moreObserve Medical ASA has today, May 21, 2021, held the Annual General Meeting. All resolutions were made in accordance with the board's and the nomination committee's proposals. The minutes from the general meeting is attached hereto and will also be available at www.observemedical.com. Björn Larsson, CEO, Observe Medical ASA Tel.: + 46 76 620 17…
Read moreOslo, 20 May 2021: In connection with the annual general meeting of Observe Medical ASA (the "Company") to be held on 21 May 2021 (the "AGM"), Terje Bakken, chairman of the board of directors of the Company, has as at the close of trading on the Oslo Stock Exchange on 20 May 2021, received proxies…
Read moreOslo, May 12[th], 2021 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the first quarter 2021, reporting continued advancement for the commercialization and go-to-market strategy Sippi®, a unique and proprietary solution for digital automated urine monitoring in hospitals. “We are continuing to execute on our go-to-market strategy, with current focus on the…
Read moreObserve Medical ASA invites you to a presentation of the first quarter 2021 on Wednesday May 12 at 8.30 CET. Due to the covid-19 situation the presentation will be held as a webcast only. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link:…
Read moreOslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): The annual general meeting of Observe Medical ASA will be held on Friday, May 21, 2021 at 09:00 (CET) in the Observe Medical offices in Henrik Ibsens gate 90 (3rd floor), 0255 Oslo. The Notice of the Annual General Meeting is attached. Due to the restrictions…
Read moreOslo, April 30, 2021 – Observe Medical ASA (OSE:OBSRV): Attached Observe Medical ASA`s annual report for 2020. The report is also available on the company's website, www.observemedical.com The annual report was reviewed and approved by the board of directors on April 29, 2021. The financial statements included in the annual report has no significant changes since…
Read moreOslo 22 March 2021 – Observe Medical ASA (OSE: OBSRV), today announces that Observe Medical Group has received a follow-up order to deliver additional quantity of safety needles to a hospital region in the Nordic market. The follow-up order represents a value of 4.2 mSEK, with planned delivery of the products during Q3 this year.…
Read moreOslo, February 23[rd], 2020 – Observe Medical ASA (OSE: OBSRV) today released its presentation of the fourth quarter 2020, reporting continued progress in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “Sippi® contributes to improved clinical outcome…
Read moreObserve Medical ASA invites you to a presentation of the fourth quarter 2020 on Tuesday February 23 at 8.30 CET. Due to the covid-19 situation the presentation will only be held as a webcast. The event will start at 08.30 CET and will be webcasted on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/landingpage/hegnarmedia/20210223_2/…
Read moreOslo 29 January 2021 – Observe Medical ASA (OSE: OBSERV), today announces that Observe Medical Group has received a significant order for medical consumables from a hospital region in the Nordic market. Following the recent acquisition and integration of Sylak AB, Observe Medical has delivered strong sales performance and today announces a significant order for…
Read moreOslo, November 3rd, 2020 – Observe Medical ASA (OSE: OBSERV) today released its presentation of the third quarter 2020, reporting important steps forward in terms of the commercialization and go-to-market strategy for its first product Sippi®. Sippi® is a unique and proprietary solution for digital automated urine monitoring in hospitals. “With Sippi®, Observe Medical contributes…
Read moreObserve Medical ASA invites you to a presentation of the third quarter 2020. The presentation will take place at Felix Konferansesenter in Oslo on Tuesday, November 3. The event will start at 08.30 CET and will be webcasted live on www.observemedical.com – Investor relations and on the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20201103_4 Due to COVID-19 and corresponding…
Read moreObserve Medical ASA, October 30, 2020: On October 29, 2020, Observe Medical announced the signing of the final agreement to acquire Sylak AB, a distributor of ICU/anaesthesia products in the Swedish market, for an enterprise value of SEK 6 million (on a cash and debt free basis). All conditions in the agreement is met, and…
Read more